Latest ads

Baseus PI LITE INDOOR CAMERA
- ErMurazor
- Updated: Today at 12:26 PM
Ad icon
Colombo Hard Disk For Sale
- mazza
- Updated: Saturday at 10:23 PM
land for sale
- justasking
- Updated: Saturday at 9:32 AM
AMD AM 5 Ryzen setup
- prabodhamadusanka
- Updated: Thursday at 12:56 PM
Gampaha ACER OKW223 Wired RGB Keyboard
- chint
- Updated: Thursday at 10:17 AM

Reply to thread

Message: <blockquote data-quote="Sri_Sampath" data-source="post: 26770067" data-attributes="member: 264139">danදැන් පේනවාsinopharm dose දෙකම ගැහුවට පස්සෙත් 79 % තමා severe වෙන එක නවතින්නේ අනින් AstraZeneca වලට 100 %<hr /><h2>Oxford/AstraZeneca vaccine</h2>1-June-21 Update:<ul> <li data-xf-list-type="ul">According to a new study from <a href="https://www.gov.uk/government/news/vaccines-highly-effective-against-b-1-617-2-variant-after-2-doses" target="_blank">Public Health England</a>, the AstraZeneca vaccine is 60% protective against the Indian variant, and 66% protective against the original UK variant. However, the authors reported that 2 full doses need to be given to be effective.</li> </ul>30-June-21 Update:<ul> <li data-xf-list-type="ul">According to <a href="https://www.google.com/url?q=https://www.reuters.com/business/healthcare-pharmaceuticals/uk-study-finds-vaccines-offer-high-protection-against-hospitalisation-delta-2021-06-14/&sa=D&source=editors&ust=1624976197754000&usg=AOvVaw12J85qizvuK1N1qyiKnK5t" target="_blank">recent studies from Public Health England</a>, the AstraZeneca vaccine provides protection against hospitalization from the Delta variant infection. The study found that the vaccine protects 92% of those infected.</li> <li data-xf-list-type="ul">A <a href="https://www.astrazeneca.com/media-centre/press-releases/2021/first-covid-19-variant-vaccine-azd2816-phase-ii-iii-trial-participants-vaccinated.html" target="_blank">new study is underway</a> to test an AstraZeneca booster shot against the South African COVID-19 variant. It is planned to involve around 2,250 volunteers.</li> <li data-xf-list-type="ul"><a href="https://www.ox.ac.uk/news/2021-06-28-delayed-second-dose-and-third-doses-oxford-astrazeneca-vaccine-lead-heightened" target="_blank">An Oxford University research team announced</a> that a delay for up to 10 months between the two doses can produce a much more robust immune response.</li> <li data-xf-list-type="ul">In addition, they found out that a third booster shot given after 6 months of the second dose can greatly strengthen protection against COVID.</li> <li data-xf-list-type="ul">The same research group announced that there is still no evidence that a third shot is actually needed.</li> </ul>1-August-21 Update:<ul> <li data-xf-list-type="ul">AstraZeneca will be testing its vaccine efficacy in 300 young children aged 6 to 17 years.</li> </ul><h2>COVISHIELD</h2>So far, three "imported variants" - British, South African, and Brazilian - have been detected in India. Serum Institute of India's COVID-19 vaccine, called Covishield, is a version of the Oxford-AstraZeneca vaccine that Indian manufacturers produce locally. This vaccine is effective against the UK and Indian variants but is awaiting efficacy data against the Brazilian strain.<h2>Sinopharm vaccine</h2>1-June-21 Update:30-June-21 Update:1-August-21 Update:<ul> <li data-xf-list-type="ul">A <a href="http://www.medrxiv.org/content/10.1101/2021.07.15.21260621v1" target="_blank">new study done in Sri Lanka</a> found that the Sinopharm vaccine induces a similar immune response against the delta variant compared to natural infection.</li> <li data-xf-list-type="ul">After conducting extensive research and trials, The UAE's Ministry of Health and Prevention (MOHAP) announced that Sinopharm Covid-19 vaccine can now be administered to children and adolescents, between age of 13-17 years.</li> </ul>------ Post added on [DATETIME="UT"]1629305570[/DATETIME]</blockquote>

Verification: Dahaya deken beduwama keeyada?

Top Bottom